The PTEN gene mutation, which is a common occurrence in glioblastoma and which occurs in 30–40% of gliomas, leads to a dysfunctional inhibition of PI3K/Akt signaling by dephosphorylation of PIP3 [88]. Here, AKT1 is linked to central nervous system cancer.